Efficacy and safety of S 47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy. A randomised, double-blind, placebo controlled international, multicentre study.
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs S 47445 (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 16 Sep 2017 Status changed from active, no longer recruiting to completed.
- 05 Sep 2017 This trial has been completed in Slovakia (End date: 2017-04-06) as per European Clinical Trials Database record.
- 01 Jun 2017 This trial has been completed in Hungary (End dat:2017-04-06) as per European Clinical Trials Database record.